Monopar Therapeutics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Monopar Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014150
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The company’s pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. Its huATN-658 targets the urokinase plasminogen activator receptor. Monopar builds development pipeline through the licensing or acquisition of orphan oncology therapeutics at the preclinical through advanced clinical development stage. The company’s lead drug product candidate is entering into clinical development through collaboration with research center in the UK. It operates in San Francisco, California, Chicago, and Illinois. Monopar is headquartered in Lake Forest, Illinois, the US.

Monopar Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Monopar Therapeutics Acquires GPX-150 from Gem Pharma 10
Venture Financing 11
Monopar Therapeutics Raises USD9.7 Million in Venture Financing 11
Monopar Therapeutics to Raise USD4.5 Million in Venture Financing 12
Monopar Therapeutics to Raise USD3 Million Financing 13
Monopar Therapeutics Raises USD2.1 Million Financing 14
Partnerships 15
Monopar Therapeutics Enters into Agreement with Cancer Research UK and Cancer Research Technology 15
Licensing Agreements 16
Monopar Therapeutics Enters into Licensing Agreement with Onxeo 16
Monopar Therapeutics LLC – Key Competitors 17
Monopar Therapeutics LLC – Key Employees 18
Monopar Therapeutics LLC – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product Approvals 20
Jan 06, 2016: Gem Pharmaceuticals Receives U.S. Orphan Drug Designation for GPX-150 in the Treatment of Patients With Sarcoma 20
Clinical Trials 21
Jun 07, 2016: Gem Pharmaceuticals Presents Promising Phase 2 Data for GPX-150 in Sarcoma Patients at the 2016 ASCO Annual Meeting 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Monopar Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Monopar Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Monopar Therapeutics Acquires GPX-150 from Gem Pharma 10
Monopar Therapeutics Raises USD9.7 Million in Venture Financing 11
Monopar Therapeutics to Raise USD4.5 Million in Venture Financing 12
Monopar Therapeutics to Raise USD3 Million Financing 13
Monopar Therapeutics Raises USD2.1 Million Financing 14
Monopar Therapeutics Enters into Agreement with Cancer Research UK and Cancer Research Technology 15
Monopar Therapeutics Enters into Licensing Agreement with Onxeo 16
Monopar Therapeutics LLC, Key Competitors 17
Monopar Therapeutics LLC, Key Employees 18

★海外企業調査レポート[Monopar Therapeutics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Photronics Inc (PLAB):企業の財務・戦略的SWOT分析
    Summary Photronics Inc (Photronics) is a manufacturer of semiconductor photomasks. The company’s products include mature binary, advanced binary reticles, embedded attenuated phase shift masks, large area masks for flat panel displays, high transmission embedded attenuated phase shift masks, alterna …
  • Elanix Biotechnologies AG (ELN):製薬・医療:M&Aディール及び事業提携情報
    Summary Elanix Biotechnologies AG (Elanix Biotechnologies), formerly Porta Systems AG, is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological and gynecological applications. The company offers GYNrepair cream and SKINrepair cream for skin care …
  • Huegli Holding AG:企業の戦略・SWOT・財務情報
    Huegli Holding AG - Strategy, SWOT and Corporate Finance Report Summary Huegli Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • juwi AG:電力:M&Aディール及び事業提携情報
    Summary juwi AG (juwi) a subsidiary of MVV Energie AG, is a renewable energy company that offers project development and engineering procurement and construction services; and products and solutions for the energy turnaround. It offers whole-scale project development services for the planning and co …
  • Global Foundries Inc:企業の戦略・SWOT・財務情報
    Global Foundries Inc - Strategy, SWOT and Corporate Finance Report Summary Global Foundries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Stena Metall AB:企業の戦略・SWOT・財務分析
    Stena Metall AB - Strategy, SWOT and Corporate Finance Report Summary Stena Metall AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Turcas Petrol AS (TRCAS):企業の財務・戦略的SWOT分析
    Summary Turcas Petrol AS (Turcas) is an oil and gas company that distributes and markets lubricants and fuel products. The company operates in the fields of oil and energy, renewable energy, power investments, natural gas projects, fuel retail and lubricants distribution, and power generation and tr …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Black & Veatch Holding Company:企業の戦略・SWOT・財務分析
    Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report Summary Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sanmina Corporation:企業の戦略・SWOT・財務情報
    Sanmina Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanmina Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Presidio Pharmaceuticals Inc (Presidio Pharmaceuticals) is a clinical-stage pharmaceutical company that discovers, develops, and supplies small-molecule antiviral therapeutics. The company’s products include HCV NS5A, protease inhibitor, ravidasvir hydrochloride, NS5B proteins, lead pan-geno …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務分析
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, …
  • Seminole Electric Cooperative, Inc.:発電所・企業SWOT分析
    Seminole Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Gammon Construction Ltd:企業の戦略的SWOT分析
    Gammon Construction Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Pareteum Corp (TEUM):企業の財務・戦略的SWOT分析
    Pareteum Corp (TEUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Deep Well Oil & Gas Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Deep Well Oil & Gas Inc (Deep Well Oil & Gas) is an oil and gas exploration and development company that acquires, explores and develops oil sands. The company operates HCSS Thermal Recovery Project and SAGD Thermal Recovery Project. Its SAGD Thermal Recovery Project operates Sawn Lake oil s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆